| Course | DNP 810 Emerging Areas of Human Health |
|---|---|
| Topic | Topic 1 |
| Paper type | Genomic nursing role paper |
| Length | About 960 words, 4 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | DNP |
| Updated | October 2026 |
Free sample paper for DNP 810 Topic 1
Who Places the Order and Who Picks Up the Result: The Advanced Nurse's Genomic Role in Four Primary Care Situations
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
DNP-810: Emerging Areas of Human Health
Topic 1 Assignment
[Instructor Name]
January 11, 2027
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Who Places the Order and Who Picks Up the Result: The Advanced Nurse's Genomic Role in Four Primary Care Situations
What the Role Is in a Clinic Where Genomic Information Arrives Routinely
At the composite rural primary care clinic where I practice as a family nurse practitioner, genomic information now arrives without anyone having planned for it: in family histories taken at annual visits, in results from specialists, in pharmacogenomic panels ordered by the cardiology practice and in reports patients bring from consumer tests. The advanced nurse's role is not to interpret variants. It is to recognize when genomic information should change what happens next, to take or arrange the action and to make sure that someone owns the result when it comes back. Professional standards for genetics and genomics nursing frame the role around assessment, identification of people who may benefit, referral and coordination, not laboratory interpretation (American Nurses Association & International Society of Nurses in Genetics, 2016).
Four Situations That Change a Decision
First, a family history that triggers referral rather than reassurance. A 38-year-old woman mentions at her annual visit that her mother had ovarian cancer at 52. The easy response is reassurance and routine screening. The correct one is a structured familial risk assessment, and, if it is positive, referral for genetic counseling and possible testing, in line with the national task force's recommendation for women with a personal or family history associated with BRCA1 or BRCA2 variants (US Preventive Services Task Force, 2019).
Second, a variant result that alters a screening interval. A patient's sister was found to carry a pathogenic variant associated with Lynch syndrome, and the patient tested positive after cascade testing arranged by the sister's counselor. His colonoscopy interval changes from every ten years to the far shorter schedule recommended for carriers, and the clinic's reminder system must be changed from the average-risk default or it will prompt him at the wrong time.
Third, a pharmacogenomic finding that rules out a first-line drug. A 62-year-old man returns from a coronary stent on clopidogrel, and his cardiologist's panel shows he is a CYP2C19 poor metabolizer. Current guidance recommends against clopidogrel for poor metabolizers after percutaneous coronary intervention and favors an alternative antiplatelet agent if there is no contraindication (Lee et al., 2022). The clinic must confirm that the cardiology practice has changed the drug, not assume it.
Fourth, an incidental result nobody asked for. A patient brings a report from exome sequencing done for her son's developmental delay, which lists a pathogenic variant in LDLR, a gene on the list of secondary findings that laboratories report because the condition, familial hypercholesterolemia, is actionable (Miller et al., 2023). She asks what it means for her. Her lipid panel, ordered that day, shows a low-density lipoprotein cholesterol of 214 mg/dL, which she has never had measured before. The finding changes her own care at once, through referral to a lipid specialist and a discussion of treatment, and it may change her relatives' care, since first-degree relatives each have about a one in two chance of carrying the same variant. Testing those relatives is arranged through a genetic counselor, but the clinic sees two of her siblings as patients, and whether they are ever offered testing depends on someone remembering to ask.
Who Owns What
In each situation, four actions are held by different people, and failures happen in the gaps between them.
Table 1
Ownership of Actions in Four Genomic Situations
| Situation | Orders | Interprets | Refers | Follows up |
|---|---|---|---|---|
| Family history of ovarian cancer | Nurse practitioner orders the risk assessment | Genetic counselor, if referred | Nurse practitioner | Nurse practitioner confirms the counseling visit happened |
| Lynch syndrome carrier | Gastroenterologist orders colonoscopy | Genetic counselor interpreted the result | Already referred | Nurse practitioner changes the reminder interval |
| CYP2C19 poor metabolizer | Cardiologist changes the antiplatelet drug | Pharmacogenomic report and cardiologist | Not needed | Nurse practitioner confirms the change at the next visit |
| Incidental LDLR variant | Nurse practitioner orders a lipid panel | Genetic counselor or lipid specialist | Nurse practitioner | Nurse practitioner tracks the referral and relatives' testing |
The Competency, Stated as Capabilities
The nurse does not need to interpret a variant to be accountable for what happens next; what the nurse must be able to do is take a family history that can identify risk, recognize which genomic results change a management decision, place or arrange the correct referral and make sure a result arriving three weeks after the visit reaches an owner. That last capability is where practices fail. A genetic result ordered at a counseling visit returns to the counselor, a pharmacogenomic panel returns to the cardiologist and a consumer report returns to no one. The primary care clinic is the only setting that sees the patient across all of them.
The Limits of the Role
Variant interpretation belongs to the laboratory and the genetic counselor, as does counseling about the meaning of a variant of uncertain significance and the psychological and family implications of testing. Deciding whether to test relatives, and how to approach them, is a counseling task. The nurse practitioner's correct action in each of those cases is referral, and knowing when to hand over is part of the competency, not a gap in it.
The Largest Gap at My Site
The largest gap between this role and current practice at my clinic is follow-up. The clinic has no way to track genetic referrals or results that return to other providers. When I reviewed the charts of the six patients referred for genetic counseling in the past year, two had no record that the counseling visit ever took place, and neither had been contacted. The fix is a referral tracking list reviewed monthly by a nurse, a small change that closes the gap the four situations share. It costs about 20 minutes a month.
References
American Nurses Association & International Society of Nurses in Genetics. (2016). Genetics/genomics nursing: Scope and standards of practice (2nd ed.).
Lee, C. R., Luzum, J. A., Sangkuhl, K., Gammal, R. S., Sabatine, M. S., Stein, C. M., Kisor, D. F., Limdi, N. A., Lee, Y. M., Scott, S. A., Hulot, J. S., Roden, D. M., Gaedigk, A., Caudle, K. E., Klein, T. E., Johnson, J. A., & Shuldiner, A. R. (2022). Clinical Pharmacogenetics Implementation Consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update. Clinical Pharmacology & Therapeutics, 112(5), 959-967. https://doi.org/10.1002/cpt.2526
Miller, D. T., Lee, K., Abul-Husn, N. S., Amendola, L. M., Brothers, K., Chung, W. K., Gollob, M. H., Gordon, A. S., Harrison, S. M., Hershberger, R. E., Klein, T. E., Richards, C. S., Stewart, D. R., & Martin, C. L. (2023). ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 25(8), Article 100866. https://doi.org/10.1016/j.gim.2023.100866
US Preventive Services Task Force. (2019). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement. JAMA, 322(7), 652-665. https://doi.org/10.1001/jama.2019.10987
Reading the GCU DNP 810 Topic 1 instructions
Topic 1 in DNP-810 asks students to define the advanced practice nurse's role in genomics within their own practice. Strong papers ground the role in situations where genomic information changes a clinical decision, rather than surveying genetics in general. Students should identify who owns each action, from taking the family history to following up the result, and state the nurse's competency as capabilities that could be observed. The paper should mark the limits of the role, such as variant interpretation and counseling about uncertain results, cite current professional guidance on genomic nursing and pharmacogenomics, and end with the largest gap between that role and current practice at the site, stated precisely enough that it could be closed.
Inside the DNP 810 Topic 1 example
The finished example is written for somebody who runs a clinic. It works from four situations in which genomic information changes what happens in a room: a family history that triggers a referral rather than reassurance, a variant result that alters a screening interval, a pharmacogenomic finding that rules out a first line drug, and an incidental result nobody asked for. Each is followed to the action it produces, including who places the order and who is responsible for the follow up when the result arrives three weeks later. Background science appears only where it explains an action, and the paper is direct that a nurse does not need to interpret a variant to be accountable for what happens next.
DNP 810 Topic 1 rubric: what Excellent looks like
Faculty reward a role defined by what changes a decision. An Excellent paper presents four situations, including a family history that warrants referral under the US Preventive Services Task Force recommendation and a CYP2C19 result for clopidogrel. Credit goes to mapping who orders, interprets, communicates and follows up, and to the ANA and ISONG scope as the frame. The rubric values capabilities that do not require interpreting a variant. Strong papers hand interpretation to the laboratory and counselor. Top marks go to naming untracked referrals and results as the gap.
DNP 810 Topic 1 help before you submit
Nothing costs more marks here than a paper that reviews inheritance patterns for a reader who studied them years ago, since the topic concerns the role rather than the science. A second failure is claiming an expanded role without naming a single order or referral it involves, which leaves the expansion unspecified. Marks also go for ignoring follow up, because a result arriving three weeks after the visit needs an owner and that is where practices actually fail. Papers that place variant interpretation inside the nurse's role overreach and misstate the referral boundary. Competency lists reproduced from a published framework demonstrate reading rather than analysis. Claims about the writer's own setting offered with no example are unverifiable.
Get a DNP-810 Topic 1 example written to your instructions
Send the DNP-810 Topic 1 instructions and the rubric your classroom posts, with any competency framework your section requires. We write a custom example to those criteria, built from situations at the level of a visit, with ownership split by task and one gap named at your own setting, in 24 to 48 hours. The first is free.
More DNP 810 papers and DNP samples
- DNP 810 Topic 2: Gene Environment Interaction Paper
- DNP 810 Topic 3: Genetic Testing Disclosure Case
- DNP 810 Topic 4: Environmental Exposure Analysis
- DNP 810 Topic 5: Emerging Threat DQ Pair
- DNP 810 Topic 6: Social Conditions Analysis
- DNP 810 Topic 7: DNP-810 Topic 7 Science to Population Paper
- DNP 810 Topic 8: Bedside Implications Synthesis
- DNP 815A Topic 1: Philosophy of Science Application
- DNP 805 Topic 1: Informatics Competency Analysis
- DNP 820 Topic 1: Translation Science Orientation
- DNP 801A Topic 1: Doctoral Expectations Paper
DNP 810 Topic 1 questions, answered
How much genetics background does the paper need?
Less than most writers include. Explain a mechanism at the point it changes an action, and skip it otherwise. A paper opening with three paragraphs on inheritance patterns has spent a fifth of its length on material the reader was examined on years ago. The topic is about what the role now involves, not about what the science says.
Where does the nurse's responsibility stop?
Short of interpreting a variant and well past ordering the test. The practical boundary is that an advanced nurse recognizes when family history warrants referral, understands what a result means for management, and owns the follow up. Detailed interpretation and counseling for a complex result belong with a genetic counselor, and naming that handover point strengthens the paper.
What makes a strong closing gap?
One that could be closed. Naming that results arrive in a general inbox with no assigned owner is specific, checkable and fixable. Concluding that the profession needs more genomic education is true, unactionable and appears in most submissions. Pick the gap you could describe to a colleague in one sentence and they would recognize immediately.
Where can I find a free DNP 810 Topic 1 sample paper?
The genomic role paper for DNP 810 Topic 1 covers the role in a clinic where results arrive routinely, four situations, who owns what, the competency as capabilities, the limits of the role and the largest gap. Send your DNP 810 Topic 1 prompt and a paper follows free.
Does the nurse need to interpret variants in DNP 810 Topic 1?
No. The nurse must take a family history that identifies risk, recognize which results change management, arrange testing or referral and ensure the result reaches the patient. Interpretation belongs to the laboratory and counselor.